US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Zenas BioPharma Inc.

28.18

+1.244.60%

Post-market: 28.180.00000.00%19:30 EDT

Volume:509.23K

Turnover:14.37M

Market Cap:1.84B

PE:-3.11

High:28.86

Open:26.89

Low:26.78

Close:26.94

52wk High:44.60

52wk Low:13.50

Shares:65.18M

Float Shares:45.02M

Volume Ratio:0.56

T/O Rate:1.13%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-9.0522

EPS(LYR):-8.4448

ROE:-199.04%

ROA:-34.42%

PB:7.43

PE(LYR):-3.34

Loading ...

Overview Company News Filings

Zenas BioPharma Outlines Monarch Phase 3 Trial Design for Orelabrutinib in Non-Active Secondary Progressive MS

Zenas Biopharma Announces Upcoming Presentations of Orelabrutinib Data in Relapsing Remitting Multiple Sclerosis, Clinical Trial Designs in Progressive Multiple Sclerosis and Other Multiple Sclerosis Portfolio Data at Mstoronto2026

THOMSON REUTERS

Zenas BioPharma to Host Virtual R&D Event on Pipeline Updates

Zenas BioPharma's Obexelimab Faces Larger IgG4-RD Opportunity, Wedbush Says

MT Newswires Live

Zenas BioPharma price target raised to $48 from $41 at Citi

Wedbush Remains a Buy on Zenas BioPharma, Inc. (ZBIO)

Zenas BioPharma Price Target Maintained with a $44.00/Share by HC Wainwright & Co.

Zenas BioPharma to Present Phase 3 Indigo Open-Label Extension Data on Obexelimab in IgG4-Related Disease at IgG4ward Symposium

Zenas Biopharma Announces Upcoming Presentations of Obexelimab Data in Igg4-Related Disease at the Igg4ward! 6TH International Symposium on Igg4-Related Disease and Acr Convergence 2026

THOMSON REUTERS

H.C. Wainwright Keeps Their Buy Rating on Zenas BioPharma, Inc. (ZBIO)

Zenas BioPharma Grants Inducement Awards of 53,700 Stock Options, 98,900 RSUs to New Hires

Zenas Biopharma Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

THOMSON REUTERS

Zenas BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Zenas BioPharma files to sell 7.0M shares of common stock for holders

Zenas Biopharma Inc Files for Offering of up to 7.0 Mln Shares of Common Stock by the Selling Stockholder - SEC Filing

THOMSON REUTERS

Citi Sticks to Its Buy Rating for Zenas BioPharma, Inc. (ZBIO)

Zenas Biopharma Outlines Obexelimab Regulatory Filings, Pipeline Milestones in Corporate Presentation

Zenas BioPharma to Host Virtual Obexelimab IgG4-RD Investor Event

Zenas BioPharma Files Form 3 Showing InnoCare Pharma Stake of 7 Million Shares

Zenas BioPharma to Present at Citi Biopharma Back to School Conference

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.tigrgood.cn/stock/ZBIO/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"ZBIO","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ZBIO\",,,,,undefined,":{"symbol":"ZBIO","market":"US","secType":"STK","nameCN":"Zenas BioPharma Inc.","latestPrice":28.18,"timestamp":1791403200000,"preClose":26.94,"halted":0,"volume":509229,"hourTrading":{"tag":"盘后","latestPrice":28.18,"preClose":28.18,"latestTime":"19:30 EDT","volume":71678,"amount":2019894.13,"timestamp":1791415801144,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.0460282108389012,"floatShares":45024692,"shares":65176700,"eps":-9.052203,"marketStatus":"Not Yet Opened","change":1.24,"latestTime":"10-07 16:00:00 EDT","open":26.89,"high":28.86,"low":26.775,"amount":14368483.885266,"amplitude":0.077394,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-9.052203,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1791446400000},"marketStatusCode":0,"adr":0,"adrRate":0,"listingDate":1726200000000,"exchange":"NASDAQ","adjPreClose":26.94,"sharesOutstanding":249967,"nav":10.0592,"aum":2514468.0464,"bidAskSpread":0,"preHourTrading":{"tag":"盘前","latestPrice":26.89,"preClose":26.94,"latestTime":"09:29 EDT","volume":513,"amount":13812.069456000001,"timestamp":1791379799999,"change":-0.05,"changeRate":-0.001856,"amplitude":0.112843},"postHourTrading":{"tag":"盘后","latestPrice":28.18,"preClose":28.18,"latestTime":"19:30 EDT","volume":71678,"amount":2019894.13,"timestamp":1791415801144,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.564775,"impliedVol":0.8325,"impliedVolPercentile":0.4582},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ZBIO\",,,,,undefined,":{"symbol":"ZBIO","floatShares":45024692,"roa":"-34.42%","roe":"-199.04%","lyrEps":-8.444814,"volumeRatio":0.564775,"shares":65176700,"dividePrice":0,"high":28.86,"amplitude":0.077394,"preClose":26.94,"low":26.775,"week52Low":13.5,"pbRate":"7.43","psRate":"1836.68","week52High":44.6,"institutionHeld":0,"latestPrice":28.18,"eps":-9.052203,"divideRate":0,"volume":509229,"delay":0,"ttmEps":-9.052203,"open":26.89,"prevYearClose":36.31,"prevWeekClose":28.295,"prevMonthClose":26.97,"prevQuarterClose":26.97,"fiveDayClose":26.97,"twentyDayClose":32.29,"sixtyDayClose":28.78},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ZBIO\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-13","symbol":"ZBIO","fiscalQuarterEnding":"2026/06","expectedEps":-0.89,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1786593600000,"reportTimeType":"pre","actualEps":-1.77},{"market":"US","date":"2026-05-13","symbol":"ZBIO","fiscalQuarterEnding":"2026/03","expectedEps":-1.37,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1778644800000,"reportTimeType":"pre","actualEps":-1.46},{"market":"US","date":"2026-03-16","symbol":"ZBIO","fiscalQuarterEnding":"2025/12","expectedEps":-1.22,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1773633600000,"reportTimeType":"pre","actualEps":-4.54},{"market":"US","date":"2025-11-12","symbol":"ZBIO","fiscalQuarterEnding":"2025/09","expectedEps":-0.87,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1762923600000,"reportTimeType":"pre","actualEps":-1.22},{"market":"US","date":"2025-08-12","symbol":"ZBIO","fiscalQuarterEnding":"2025/06","expectedEps":-1.02,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1754971200000,"reportTimeType":"pre","actualEps":-1.25}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ZBIO\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ZBIO\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.625,"buy":0.25,"hold":0.125,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":0.625,"analysts":8,"updateTime":1767758400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ZBIO\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ZBIO","date":"2026-10-06","current":-3.113054,"percent":0.533981,"low":-19.592941,"twenty":-7.18226,"median":-3.950232,"eighty":-2.638618,"high":-1.802568,"avg":-5.242411,"sd":3.628847,"marketCap":1813868201},"quantilePoints":[{"date":"2024-09-13","current":-8.364044,"twenty":-11.189626,"median":-10.130033,"eighty":-9.07044,"marketCap":457989962},{"date":"2024-09-20","current":-12.731934,"twenty":-12.968841,"median":-12.731934,"eighty":-9.523082,"marketCap":697162515},{"date":"2024-09-27","current":-12.564791,"twenty":-13.484804,"median":-12.909978,"eighty":-12.029776,"marketCap":688010267},{"date":"2024-10-04","current":-14.275075,"twenty":-13.747873,"median":-12.811872,"eighty":-12.31335,"marketCap":781660299},{"date":"2024-10-11","current":-13.008553,"twenty":-13.941177,"median":-13.027627,"eighty":-12.397648,"marketCap":712309358},{"date":"2024-10-18","current":-16.373229,"twenty":-14.273549,"median":-13.29848,"eighty":-12.477586,"marketCap":896548905},{"date":"2024-10-25","current":-17.845752,"twenty":-15.022781,"median":-13.503182,"eighty":-12.59822,"marketCap":977179818},{"date":"2024-10-31","current":-16.022265,"twenty":-16.022265,"median":-13.891034,"eighty":-12.731934,"marketCap":877331175},{"date":"2024-11-08","current":-15.961228,"twenty":-15.961228,"median":-14.267446,"eighty":-12.811872,"marketCap":873988961},{"date":"2024-11-15","current":-6.06727,"twenty":-16.022265,"median":-14.202594,"eighty":-12.564791,"marketCap":782495852},{"date":"2024-11-22","current":-3.382919,"twenty":-15.961228,"median":-13.807463,"eighty":-11.896022,"marketCap":436298426},{"date":"2024-11-29","current":-3.729636,"twenty":-15.955124,"median":-13.496851,"eighty":-6.578437,"marketCap":481014835},{"date":"2024-12-06","current":-3.402361,"twenty":-15.898664,"median":-13.178717,"eighty":-4.851473,"marketCap":438805888},{"date":"2024-12-13","current":-2.997318,"twenty":-15.744546,"median":-13.008553,"eighty":-3.729636,"marketCap":386567092},{"date":"2024-12-20","current":-3.162575,"twenty":-15.636205,"median":-12.771903,"eighty":-3.606503,"marketCap":407880521},{"date":"2024-12-27","current":-3.256545,"twenty":-15.585849,"median":-12.510288,"eighty":-3.394584,"marketCap":419999921},{"date":"2025-01-03","current":-2.91955,"twenty":-15.427152,"median":-12.339512,"eighty":-3.24488,"marketCap":376537243},{"date":"2025-01-10","current":-3.007039,"twenty":-15.189107,"median":-10.412935,"eighty":-3.188498,"marketCap":387820823},{"date":"2025-01-17","current":-2.520987,"twenty":-15.022781,"median":-6.676265,"eighty":-3.159983,"marketCap":325134267},{"date":"2025-01-24","current":-2.715408,"twenty":-14.870188,"median":-6.06727,"eighty":-3.071846,"marketCap":350208890},{"date":"2025-01-31","current":-2.469142,"twenty":-14.351372,"median":-4.794107,"eighty":-2.968155,"marketCap":318447701},{"date":"2025-02-07","current":-2.54367,"twenty":-14.313224,"median":-3.888412,"eighty":-2.841781,"marketCap":328059640},{"date":"2025-02-14","current":-2.313605,"twenty":-14.275075,"median":-3.716674,"eighty":-2.653842,"marketCap":298388004},{"date":"2025-02-21","current":-2.530708,"twenty":-14.268972,"median":-3.643766,"eighty":-2.622086,"marketCap":326387998},{"date":"2025-02-28","current":-2.141867,"twenty":-14.163683,"median":-3.476889,"eighty":-2.54367,"marketCap":276238754},{"date":"2025-03-07","current":-2.35573,"twenty":-14.007233,"median":-3.332693,"eighty":-2.517747,"marketCap":303820838},{"date":"2025-03-14","current":-2.324434,"twenty":-13.840892,"median":-3.246824,"eighty":-2.465902,"marketCap":364908203},{"date":"2025-03-21","current":-2.26852,"twenty":-13.569102,"median":-3.188498,"eighty":-2.360915,"marketCap":356130342},{"date":"2025-03-28","current":-2.138053,"twenty":-13.499383,"median":-3.165816,"eighty":-2.351842,"marketCap":335648668},{"date":"2025-04-04","current":-2.076814,"twenty":-13.408148,"median":-3.159335,"eighty":-2.284767,"marketCap":326034820},{"date":"2025-04-11","current":-1.80523,"twenty":-13.315978,"median":-3.071846,"eighty":-2.26652,"marketCap":283399498},{"date":"2025-04-17","current":-2.21793,"twenty":-13.154764,"median":-2.997318,"eighty":-2.257224,"marketCap":348188468},{"date":"2025-04-25","current":-2.657256,"twenty":-13.051602,"median":-2.943853,"eighty":-2.261324,"marketCap":417157373},{"date":"2025-05-02","current":-3.077944,"twenty":-13.023813,"median":-2.968155,"eighty":-2.26639,"marketCap":483200324},{"date":"2025-05-09","current":-2.4756,"twenty":-13.008271,"median":-2.943853,"eighty":-2.269325,"marketCap":388639550},{"date":"2025-05-16","current":-2.503456,"twenty":-12.890356,"median":-2.890387,"eighty":-2.270833,"marketCap":407464932},{"date":"2025-05-23","current":-2.942974,"twenty":-12.763909,"median":-2.866084,"eighty":-2.272453,"marketCap":479001383},{"date":"2025-05-30","current":-2.570283,"twenty":-12.665077,"median":-2.835832,"eighty":-2.278934,"marketCap":418341820},{"date":"2025-06-06","current":-2.470042,"twenty":-12.521189,"median":-2.721889,"eighty":-2.297829,"marketCap":402026489},{"date":"2025-06-13","current":-2.90956,"twenty":-12.426717,"median":-2.835832,"eighty":-2.31327,"marketCap":473562940},{"date":"2025-06-20","current":-2.392933,"twenty":-12.365673,"median":-2.76689,"eighty":-2.315238,"marketCap":389476234},{"date":"2025-06-27","current":-2.608837,"twenty":-12.215932,"median":-2.714219,"eighty":-2.322158,"marketCap":424616947},{"date":"2025-07-03","current":-2.577994,"twenty":-11.896022,"median":-2.691086,"eighty":-2.323707,"marketCap":419596845},{"date":"2025-07-11","current":-3.102331,"twenty":-8.929847,"median":-2.679496,"eighty":-2.324434,"marketCap":504938576},{"date":"2025-07-18","current":-3.387633,"twenty":-8.364044,"median":-2.699206,"eighty":-2.336288,"marketCap":551374518},{"date":"2025-07-25","current":-4.194702,"twenty":-6.676265,"median":-2.718649,"eighty":-2.349239,"marketCap":682733850},{"date":"2025-08-01","current":-4.037914,"twenty":-6.187126,"median":-2.829882,"eighty":-2.35573,"marketCap":657214999},{"date":"2025-08-08","current":-3.804019,"twenty":-6.06727,"median":-2.865865,"eighty":-2.35573,"marketCap":619145893},{"date":"2025-08-15","current":-3.987237,"twenty":-5.542498,"median":-2.90956,"eighty":-2.36209,"marketCap":705768845},{"date":"2025-08-22","current":-4.02768,"twenty":-4.889717,"median":-2.928692,"eighty":-2.362211,"marketCap":712927599},{"date":"2025-08-29","current":-3.868286,"twenty":-4.698498,"median":-2.950685,"eighty":-2.372371,"marketCap":684713689},{"date":"2025-09-05","current":-4.039575,"twenty":-4.396216,"median":-2.982091,"eighty":-2.374493,"marketCap":715033114},{"date":"2025-09-12","current":-4.798483,"twenty":-4.881439,"median":-2.99503,"eighty":-2.389351,"marketCap":849365013},{"date":"2025-09-19","current":-4.629572,"twenty":-4.881439,"median":-3.063777,"eighty":-2.399463,"marketCap":819466690},{"date":"2025-09-26","current":-4.429735,"twenty":-4.835595,"median":-3.074895,"eighty":-2.402603,"marketCap":784094028},{"date":"2025-10-03","current":-4.984046,"twenty":-4.911724,"median":-3.083269,"eighty":-2.409912,"marketCap":882211057},{"date":"2025-10-10","current":-6.604159,"twenty":-5.180553,"median":-3.135974,"eighty":-2.413574,"marketCap":1168982288},{"date":"2025-10-17","current":-5.759607,"twenty":-5.320916,"median":-3.162575,"eighty":-2.420654,"marketCap":1019490677},{"date":"2025-10-24","current":-5.949928,"twenty":-5.76722,"median":-3.174048,"eighty":-2.42495,"marketCap":1053178928},{"date":"2025-10-31","current":-9.035303,"twenty":-6.083769,"median":-3.188498,"eighty":-2.432369,"marketCap":1599311910},{"date":"2025-11-07","current":-9.81546,"twenty":-6.198298,"median":-3.245204,"eighty":-2.444339,"marketCap":1737405107},{"date":"2025-11-14","current":-10.08009,"twenty":-6.457611,"median":-3.282468,"eighty":-2.446909,"marketCap":1914199059},{"date":"2025-11-21","current":-9.848299,"twenty":-7.258864,"median":-3.371139,"eighty":-2.451734,"marketCap":1870182143},{"date":"2025-11-28","current":-10.976161,"twenty":-8.972029,"median":-3.394997,"eighty":-2.453948,"marketCap":2084362015},{"date":"2025-12-05","current":-10.772637,"twenty":-9.459248,"median":-3.515773,"eighty":-2.459247,"marketCap":2045713016},{"date":"2025-12-12","current":-11.366249,"twenty":-9.83041,"median":-3.643766,"eighty":-2.466418,"marketCap":2158439264},{"date":"2025-12-19","current":-9.913314,"twenty":-9.980024,"median":-3.678075,"eighty":-2.469682,"marketCap":1882528351},{"date":"2025-12-26","current":-12.202958,"twenty":-10.134363,"median":-3.729636,"eighty":-2.472265,"marketCap":2317329596},{"date":"2026-01-02","current":-10.263827,"twenty":-10.232168,"median":-3.760324,"eighty":-2.476253,"marketCap":1949090517},{"date":"2026-01-09","current":-4.638651,"twenty":-10.207521,"median":-3.79333,"eighty":-2.479511,"marketCap":880875114},{"date":"2026-01-16","current":-5.633657,"twenty":-10.159019,"median":-3.831007,"eighty":-2.483289,"marketCap":1069825778},{"date":"2026-01-23","current":-5.766513,"twenty":-10.142278,"median":-3.88256,"eighty":-2.488034,"marketCap":1095054986},{"date":"2026-01-30","current":-5.902195,"twenty":-10.122491,"median":-3.950232,"eighty":-2.490604,"marketCap":1120820986},{"date":"2026-02-06","current":-5.938943,"twenty":-10.119664,"median":-3.975342,"eighty":-2.498305,"marketCap":1127799277},{"date":"2026-02-13","current":-7.380571,"twenty":-10.08009,"median":-4.008147,"eighty":-2.503456,"marketCap":1401563024},{"date":"2026-02-20","current":-7.637803,"twenty":-9.946669,"median":-4.026371,"eighty":-2.50452,"marketCap":1450411065},{"date":"2026-02-27","current":-7.451239,"twenty":-9.897484,"median":-4.035344,"eighty":-2.514003,"marketCap":1414982815},{"date":"2026-03-06","current":-7.140299,"twenty":-9.857345,"median":-4.041954,"eighty":-2.520051,"marketCap":1355935733},{"date":"2026-03-13","current":-6.925469,"twenty":-9.824447,"median":-4.068124,"eighty":-2.528764,"marketCap":1315139567},{"date":"2026-03-20","current":-3.549457,"twenty":-9.816065,"median":-4.041954,"eighty":-2.535893,"marketCap":1340761298},{"date":"2026-03-27","current":-3.365681,"twenty":-9.764845,"median":-4.035344,"eighty":-2.542374,"marketCap":1271342335},{"date":"2026-04-02","current":-3.206266,"twenty":-9.752191,"median":-4.02768,"eighty":-2.54367,"marketCap":1211125146},{"date":"2026-04-10","current":-3.351146,"twenty":-9.585134,"median":-4.008147,"eighty":-2.555011,"marketCap":1265851823},{"date":"2026-04-17","current":-3.426736,"twenty":-9.459248,"median":-3.975342,"eighty":-2.562572,"marketCap":1294404871},{"date":"2026-04-24","current":-2.91178,"twenty":-9.318941,"median":-3.950232,"eighty":-2.56484,"marketCap":1099887227},{"date":"2026-05-01","current":-3.042488,"twenty":-9.220114,"median":-3.88256,"eighty":-2.568711,"marketCap":1149260207},{"date":"2026-05-08","current":-3.034614,"twenty":-9.118797,"median":-3.818719,"eighty":-2.573367,"marketCap":1146285931},{"date":"2026-05-15","current":-2.806581,"twenty":-9.04377,"median":-3.782641,"eighty":-2.576966,"marketCap":1193220825},{"date":"2026-05-22","current":-2.946168,"twenty":-8.972029,"median":-3.74498,"eighty":-2.576966,"marketCap":1252566199},{"date":"2026-05-29","current":-2.756092,"twenty":-8.703526,"median":-3.716674,"eighty":-2.577994,"marketCap":1171755477},{"date":"2026-06-05","current":-2.729363,"twenty":-8.073548,"median":-3.672934,"eighty":-2.577994,"marketCap":1160391469},{"date":"2026-06-12","current":-2.637295,"twenty":-7.609535,"median":-3.597675,"eighty":-2.580331,"marketCap":1121248775},{"date":"2026-06-18","current":-2.759062,"twenty":-7.566764,"median":-3.544789,"eighty":-2.584211,"marketCap":1173018144},{"date":"2026-06-26","current":-3.663405,"twenty":-7.560564,"median":-3.528998,"eighty":-2.58741,"marketCap":1557500410},{"date":"2026-07-02","current":-4.157898,"twenty":-7.541694,"median":-3.549457,"eighty":-2.594231,"marketCap":1767734556},{"date":"2026-07-10","current":-4.370248,"twenty":-7.462546,"median":-3.643766,"eighty":-2.595516,"marketCap":1858015285},{"date":"2026-07-17","current":-4.193537,"twenty":-7.451239,"median":-3.672934,"eighty":-2.596017,"marketCap":1782886566},{"date":"2026-07-24","current":-4.601902,"twenty":-7.448412,"median":-3.716674,"eighty":-2.598756,"marketCap":1956503353},{"date":"2026-07-31","current":-4.791978,"twenty":-7.400923,"median":-3.74498,"eighty":-2.598756,"marketCap":2037314075},{"date":"2026-08-07","current":-4.777128,"twenty":-7.389051,"median":-3.770746,"eighty":-2.606821,"marketCap":2031000738},{"date":"2026-08-14","current":-3.929032,"twenty":-7.382267,"median":-3.79905,"eighty":-2.610296,"marketCap":1903160311},{"date":"2026-08-21","current":-4.254657,"twenty":-7.371525,"median":-3.831007,"eighty":-2.614149,"marketCap":2060887981},{"date":"2026-08-28","current":-4.389213,"twenty":-7.360218,"median":-3.875423,"eighty":-2.618299,"marketCap":2126064704},{"date":"2026-09-04","current":-4.42958,"twenty":-7.333082,"median":-3.927729,"eighty":-2.626159,"marketCap":2145617721},{"date":"2026-09-11","current":-4.184688,"twenty":-7.320079,"median":-3.939657,"eighty":-2.629863,"marketCap":2026996085},{"date":"2026-09-18","current":-4.301752,"twenty":-7.30538,"median":-3.973043,"eighty":-2.631159,"marketCap":2083699834},{"date":"2026-09-25","current":-3.700287,"twenty":-7.254499,"median":-3.975342,"eighty":-2.634841,"marketCap":1792359882},{"date":"2026-10-02","current":-3.759492,"twenty":-7.199396,"median":-3.965775,"eighty":-2.638089,"marketCap":1821037640},{"date":"2026-10-06","current":-3.744691,"twenty":-7.18226,"median":-3.950232,"eighty":-2.638618,"marketCap":1813868201}],"updateTime":1791417806516},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ZBIO\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2673097313","title":"Zenas BioPharma Outlines Monarch Phase 3 Trial Design for Orelabrutinib in Non-Active Secondary Progressive MS","url":"https://stock-news.laohu8.com/highlight/detail?id=2673097313","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673097313?lang=en_us&edition=fundamental","pubTime":"2026-10-07 19:05","pubTimestamp":1791371132,"startTime":"0","endTime":"0","summary":"Zenas BioPharma outlines Monarch Phase 3 trial design for orelabrutinib in non-active secondary progressive MSZenas BioPharma flagged seven posters for MSToronto2026 on Oct. 21-23, 2026, outlining ore","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261007:nNDL2Bj9nR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B64PRP62.GBP","LU2095319765.USD","SG9999014021.USD","SG9999014013.SGD","IE00B3QW5Z07.USD","LU2210149790.SGD","SG9999014039.USD","LU2210150020.SGD","BK4112","LU0314104364.USD","IE00BQXX3C00.GBP","IE00BN0W2T93.GBP","BK4588","BK4139","SG9999014005.SGD","IE00BQXX3D17.EUR","NDAQ","IE00BN0W2W23.USD","IE00BKPKM429.USD","ZBIO","IE00BGHQF748.EUR","BK4585","IE00BN0W2V16.EUR","IE00BQXX3F31.USD","BCDF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673209736","title":"Zenas Biopharma Announces Upcoming Presentations of Orelabrutinib Data in Relapsing Remitting Multiple Sclerosis, Clinical Trial Designs in Progressive Multiple Sclerosis and Other Multiple Sclerosis Portfolio Data at Mstoronto2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2673209736","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673209736?lang=en_us&edition=fundamental","pubTime":"2026-10-07 19:05","pubTimestamp":1791371100,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261007:nTUABCLKKF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","ZBIO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673405374","title":"Zenas BioPharma to Host Virtual R&D Event on Pipeline Updates","url":"https://stock-news.laohu8.com/highlight/detail?id=2673405374","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673405374?lang=en_us&edition=fundamental","pubTime":"2026-10-06 19:05","pubTimestamp":1791284725,"startTime":"0","endTime":"0","summary":"Zenas BioPharma to host virtual R&D event on pipeline updatesZenas BioPharma will host a virtual R&D event on Oct. 27, 2026, from 8:00 a.m. to 9:30 a.m. ET.Management will outline the R&D pipeline, wi","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261006:nNDL7l0yXB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NDAQ","SG9999014005.SGD","BCDF","IE00BN0W2W23.USD","IE00BQXX3F31.USD","BK4588","BK4112","IE00BGHQF748.EUR","IE00BN0W2V16.EUR","LU0314104364.USD","IE00B64PRP62.GBP","LU2210149790.SGD","SG9999014021.USD","SG9999014039.USD","ZBIO","BK4585","LU2095319765.USD","IE00BQXX3D17.EUR","SG9999014013.SGD","IE00BQXX3C00.GBP","BK4139","IE00BKPKM429.USD","IE00B3QW5Z07.USD","IE00BN0W2T93.GBP","LU2210150020.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671785969","title":"Zenas BioPharma's Obexelimab Faces Larger IgG4-RD Opportunity, Wedbush Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2671785969","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671785969?lang=en_us&edition=fundamental","pubTime":"2026-09-30 23:33","pubTimestamp":1790782431,"startTime":"0","endTime":"0","summary":"Zenas BioPharma's  investor update supports a larger addressable market for obexelimab in immunoglobulin G4-related disease, with room for market penetration and potential safety differentiation, Wedbush said in a Wednesday note.Zenas increased its estimate to about 30,000 to 40,000 prevalent US IgG4-related disease cases, including about 25,000 diagnosed and treated patients, and now estimates a roughly $4 billion commercial opportunity in the US, the firm noted. Wedbush attributed the increase to improved diagnosis.The firm noted Zenas' estimate that Uplizna, the only approved competitor, has reached about 1,200 unique patients 16 months after launch.The firm said the data and physician feedback support an opportunity for advanced treatments beyond as-needed glucocorticoids, with significant unmet need remaining.Wedbush reiterated its outperform rating and $45 price target.Price: 28.29, Change: +1.53, Percent Change: +5.72","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ZBIO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671519788","title":"Zenas BioPharma price target raised to $48 from $41 at Citi","url":"https://stock-news.laohu8.com/highlight/detail?id=2671519788","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671519788?lang=en_us&edition=fundamental","pubTime":"2026-09-30 22:10","pubTimestamp":1790777428,"startTime":"0","endTime":"0","summary":"Citi raised the firm’s price target on Zenas BioPharma (ZBIO) to $48 from $41 and keeps a Buy rating on the shares after updating the firm’s obexel...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/zenas-biopharma-price-target-raised-to-48-from-41-at-citi-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/zenas-biopharma-price-target-raised-to-48-from-41-at-citi-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ZBIO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671055207","title":"Wedbush Remains a Buy on Zenas BioPharma, Inc. (ZBIO)","url":"https://stock-news.laohu8.com/highlight/detail?id=2671055207","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671055207?lang=en_us&edition=fundamental","pubTime":"2026-09-30 21:25","pubTimestamp":1790774749,"startTime":"0","endTime":"0","summary":"In a report released today, from Wedbush maintained a Buy rating on Zenas BioPharma, Inc., with a price target of $45.00. Zenas BioPharma, Inc. has...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/wedbush-remains-a-buy-on-zenas-biopharma-inc-zbio-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/wedbush-remains-a-buy-on-zenas-biopharma-inc-zbio-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ZBIO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671053262","title":"Zenas BioPharma Price Target Maintained with a $44.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2671053262","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671053262?lang=en_us&edition=fundamental","pubTime":"2026-09-30 18:39","pubTimestamp":1790764740,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ZBIO/analyst-ratings","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ZBIO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669146176","title":"Zenas BioPharma to Present Phase 3 Indigo Open-Label Extension Data on Obexelimab in IgG4-Related Disease at IgG4ward Symposium","url":"https://stock-news.laohu8.com/highlight/detail?id=2669146176","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669146176?lang=en_us&edition=fundamental","pubTime":"2026-09-22 19:05","pubTimestamp":1790075117,"startTime":"0","endTime":"0","summary":"Zenas BioPharma to present Phase 3 INDIGO open-label extension data on obexelimab in IgG4-related disease at IgG4ward symposiumZenas Biopharma scheduled new Phase 3 INDIGO obexelimab updates in IgG4-r","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260922:nNDL5ZTZ5Q:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014039.USD","SG9999014021.USD","BK4112","IE00BQXX3D17.EUR","BK4139","IE00BQXX3F31.USD","LU2095319765.USD","NDAQ","BK4588","IE00B64PRP62.GBP","LU0314104364.USD","LU2210149790.SGD","SG9999014013.SGD","IE00BGHQF748.EUR","IE00BN0W2W23.USD","IE00BQXX3C00.GBP","IE00BN0W2V16.EUR","LU2210150020.SGD","ZBIO","BK4585","IE00BKPKM429.USD","IE00B3QW5Z07.USD","SG9999014005.SGD","IE00BN0W2T93.GBP","BCDF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669146119","title":"Zenas Biopharma Announces Upcoming Presentations of Obexelimab Data in Igg4-Related Disease at the Igg4ward! 6TH International Symposium on Igg4-Related Disease and Acr Convergence 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2669146119","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669146119?lang=en_us&edition=fundamental","pubTime":"2026-09-22 19:05","pubTimestamp":1790075100,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260922:nTUA9MFYDW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ZBIO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669167073","title":"H.C. Wainwright Keeps Their Buy Rating on Zenas BioPharma, Inc. (ZBIO)","url":"https://stock-news.laohu8.com/highlight/detail?id=2669167073","media":"TIPRANKS","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669167073?lang=en_us&edition=fundamental","pubTime":"2026-09-22 01:57","pubTimestamp":1790013438,"startTime":"0","endTime":"0","summary":"In a report released today, Matthew Caufield from H.C. Wainwright maintained a Buy rating on Zenas BioPharma, Inc., with a price target of $44.00. ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/h-c-wainwright-keeps-their-buy-rating-on-zenas-biopharma-inc-zbio-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/h-c-wainwright-keeps-their-buy-rating-on-zenas-biopharma-inc-zbio-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ZBIO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668973382","title":"Zenas BioPharma Grants Inducement Awards of 53,700 Stock Options, 98,900 RSUs to New Hires","url":"https://stock-news.laohu8.com/highlight/detail?id=2668973382","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668973382?lang=en_us&edition=fundamental","pubTime":"2026-09-19 04:15","pubTimestamp":1789762518,"startTime":"0","endTime":"0","summary":"Zenas BioPharma grants inducement awards of 53,700 stock options, 98,900 RSUs to new hiresZenas BioPharma set inducement awards dated Sept. 15, 2026 for newly hired employees: stock options for 53,700","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260918:nNDL6kFgK0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014039.USD","SG9999014021.USD","BK4112","IE00BQXX3D17.EUR","BK4139","IE00BQXX3F31.USD","LU2095319765.USD","NDAQ","BK4588","IE00B64PRP62.GBP","LU0314104364.USD","LU2210149790.SGD","SG9999014013.SGD","IE00BGHQF748.EUR","IE00BN0W2W23.USD","IE00BQXX3C00.GBP","IE00BN0W2V16.EUR","LU2210150020.SGD","ZBIO","BK4585","IE00BKPKM429.USD","IE00B3QW5Z07.USD","SG9999014005.SGD","IE00BN0W2T93.GBP","BCDF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668197387","title":"Zenas Biopharma Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2668197387","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668197387?lang=en_us&edition=fundamental","pubTime":"2026-09-19 04:15","pubTimestamp":1789762500,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260918:nTUA880NBN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ZBIO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668973302","title":"Zenas BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2668973302","media":"GlobeNewswire","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668973302?lang=en_us&edition=fundamental","pubTime":"2026-09-19 04:15","pubTimestamp":1789762500,"startTime":"0","endTime":"0","summary":"WALTHAM, Mass., Sept.  18, 2026 (GLOBE NEWSWIRE) -- Zenas BioPharma, Inc. (“Zenas” or the “Company”) (Nasdaq: ZBIO), a clinical-stage global biopharmaceutical company committed to being a leader in th","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/18/3364945/0/en/zenas-biopharma-announces-inducement-grants-under-nasdaq-listing-rule-5635-c-4.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ZBIO","LCLG","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666574753","title":"Zenas BioPharma files to sell 7.0M shares of common stock for holders","url":"https://stock-news.laohu8.com/highlight/detail?id=2666574753","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666574753?lang=en_us&edition=fundamental","pubTime":"2026-09-12 04:55","pubTimestamp":1789160110,"startTime":"0","endTime":"0","summary":"16:50 EDT Zenas BioPharma (ZBIO) files to sell 7.0M shares of common stock for holders Published first on TheFly – the ultimate source for real-tim...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/zenas-biopharma-files-to-sell-7-0m-shares-of-common-stock-for-holders-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/zenas-biopharma-files-to-sell-7-0m-shares-of-common-stock-for-holders-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","ZBIO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666257419","title":"Zenas Biopharma Inc Files for Offering of up to 7.0 Mln Shares of Common Stock by the Selling Stockholder - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2666257419","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666257419?lang=en_us&edition=fundamental","pubTime":"2026-09-12 04:50","pubTimestamp":1789159847,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260911:nFWN4530GH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ZBIO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666542239","title":"Citi Sticks to Its Buy Rating for Zenas BioPharma, Inc. (ZBIO)","url":"https://stock-news.laohu8.com/highlight/detail?id=2666542239","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666542239?lang=en_us&edition=fundamental","pubTime":"2026-09-11 16:16","pubTimestamp":1789114580,"startTime":"0","endTime":"0","summary":"Citi analyst Yigal Nochomovitz maintained a Buy rating on Zenas BioPharma, Inc. yesterday and set a price target of $41.00. The company’s shares cl...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/citi-sticks-to-its-buy-rating-for-zenas-biopharma-inc-zbio-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/citi-sticks-to-its-buy-rating-for-zenas-biopharma-inc-zbio-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ZBIO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666725293","title":"Zenas Biopharma Outlines Obexelimab Regulatory Filings, Pipeline Milestones in Corporate Presentation","url":"https://stock-news.laohu8.com/highlight/detail?id=2666725293","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666725293?lang=en_us&edition=fundamental","pubTime":"2026-09-09 03:10","pubTimestamp":1788894657,"startTime":"0","endTime":"0","summary":"Zenas Biopharma outlines obexelimab regulatory filings, pipeline milestones in corporate presentationZenas Biopharma highlighted FDA acceptance of its BLA for obexelimab in IgG4-related disease, with ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nNDL4wMsKQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ZBIO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665322486","title":"Zenas BioPharma to Host Virtual Obexelimab IgG4-RD Investor Event","url":"https://stock-news.laohu8.com/highlight/detail?id=2665322486","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665322486?lang=en_us&edition=fundamental","pubTime":"2026-09-08 19:06","pubTimestamp":1788865589,"startTime":"0","endTime":"0","summary":"Zenas BioPharma to host virtual obexelimab IgG4-RD investor eventZenas BioPharma will host a virtual obexelimab IgG4-RD investor event on Sept. 29, 2026, from 8:00-9:30 a.m. ET.Session will cover IgG4","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nNDL7NMmdF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BN0W2T93.GBP","SG9999014013.SGD","IE00B64PRP62.GBP","NDAQ","IE00BQXX3D17.EUR","IE00BKPKM429.USD","SG9999014039.USD","IE00BGHQF748.EUR","BK4139","BK4588","IE00BN0W2W23.USD","SG9999014005.SGD","IE00BN0W2V16.EUR","IE00BQXX3C00.GBP","ZBIO","BK4112","IE00B3QW5Z07.USD","LU2210149790.SGD","BK4585","IE00BQXX3F31.USD","SG9999014021.USD","LU2210150020.SGD","LU2095319765.USD","LU0314104364.USD","BCDF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665632404","title":"Zenas BioPharma Files Form 3 Showing InnoCare Pharma Stake of 7 Million Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2665632404","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665632404?lang=en_us&edition=fundamental","pubTime":"2026-09-08 18:51","pubTimestamp":1788864714,"startTime":"0","endTime":"0","summary":"Zenas BioPharma files Form 3 showing InnoCare Pharma stake of 7 million sharesZenas BioPharma disclosed a new Form 3 filing showing InnoCare Pharma as a 10% owner.InnoCare reported direct ownership of","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nNDLbkwprv:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["688428","BK0239","ZBIO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664233674","title":"Zenas BioPharma to Present at Citi Biopharma Back to School Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2664233674","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664233674?lang=en_us&edition=fundamental","pubTime":"2026-09-04 19:05","pubTimestamp":1788519915,"startTime":"0","endTime":"0","summary":"Zenas BioPharma to present at Citi Biopharma Back to School ConferenceZenas BioPharma management will present at the Citi Biopharma Back to School Conference on Sept. 9, 2026 at 4:20 p.m. ET.The compa","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260904:nNDL2wWLcn:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0310800965.SGD","TFNS","FTXO","BCDF","LU1201861249.SGD","LU0557290698.USD","LU1244550577.SGD","LU2125154935.USD","LU2357305700.SGD","LU0106261372.USD","LU1720051017.SGD","SG9999014021.USD","LU1720051108.HKD","LU2462157665.USD","LU0980610538.SGD","IE00BKVL7J92.USD","LU0225283273.USD","IE00B3QW5Z07.USD","SG9999014039.USD","IE00BKPKM429.USD","LU0795875169.SGD","IE00BQXX3F31.USD","LU0128525689.USD","IE00BQXX3C00.GBP","ZBIO","IE00BN0W2T93.GBP","IYF","BK4581","LU1244550494.USD","NDAQ","BK4559","LU0795875086.SGD","LU2264538146.SGD","LU0158827781.USD","LU2456880835.USD","LU0267386448.USD","LU2095319765.USD","LU2417539215.USD","LU0052756011.USD","LU1366192091.USD","IE00B3S45H60.SGD","KBWB","LU1144417596.USD","IE00BN0W2W23.USD","LU0390134368.USD","LU0477156953.USD","BK4127","IAI","LU1506573853.SGD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":6,"pageCount":1,"totalSize":102,"code":"91000000","status":"200"}]}}